Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P000009/S128

BIOexpress

Biotronik, Inc. · Decision date Oct 16, 2026

MEDTECHLEDGER EXPLANATIONP000009/S128

What did the FDA approve?

BIOexpress is described in the source statement as a dedicated interrogation-only device for status checks of BIOTRONIK implantable pulse generators (IPGs, CRT-Ps), implantable cardioverter defibrillators (ICDs, CRT-Ds) and implantable cardiac monitors (ICMs). The listed device category is DEFIBRILLATOR, IMPLANTABLE, DUAL-CHAMBER, with product code MRM under the Cardiovascular specialty.

The decision is an approval of supplement S128 to PMA P000009, filed on the Normal 180 Day Track with the stated reason Change Design/Components/Specifications/Material. That reason names a change category without identifying the specific component or specification altered, so the exact changed item cannot be determined from the supplied fields, and the supplement does not amount to a new approval of the whole system.

The source statement reports device purpose; it does not independently establish safety or clinical effectiveness.

FDA approval order statement

BIOexpress, a dedicated interrogation-only device for status checks of BIOTRONIK implantable pulse generators (IPGs, CRT-Ps), implantable cardioverter defibrillators (ICDs, CRT-Ds) and implantable cardiac monitors (ICMs)
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track
Clinical specialty
Cardiovascular
Decision date
Oct 16, 2026
FDA change category
Change Design/Components/Specifications/Material

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P000009/S128
Regulatory pathway
PMA supplement
Product code
MRM
Decision code
APPR
Decision date
Oct 16, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: DEFIBRILLATOR, IMPLANTABLE, DUAL-CHAMBER.

Product code
MRM
FDA device class
3

For the original device and its historical approval scope, see PMA P000009. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P000009 · Original PMA

    PHYLAX AV ICD SYSTEM

  2. P000009/S128 received

    Application receipt date recorded by FDA.

  3. P000009/S130 · Related supplement

    PSW 2601.U, NEO 2601.U, Acticor Sky DR-T, Rivacor Sky DR-T, Rivacor Rise DR-T, Rivacor Aura DR-T

  4. P000009/S124 · Related supplement

    Ilivia Neo 7 DR-T 429529; Intica Neo 7 DR-T 429558; Intica Neo 5 DR-T 429568

  5. P000009/S133 · Related supplement

    Acticor Sky DR-T, Rivacor Sky DR-T, Rivacor Rise DR-T, Rivacor Aura DR-T, Acticor 7 DR-T, Rivacor 7 DR-T, Rivacor 5 DR-T

  6. P000009/S132 · Related supplement

    Acticor Sky DR-T 481987; Rivacor Sky DR-T 481982; Rivacor Rise DR-T 482018; Rivacor Aura DR-T 482014

  7. P000009/S134 · Related supplement

    Intica Neo 7 DR-T DF-1 ProMRI, Intica Neo 5 DR-T DF-1 ProMRI

  8. P000009/S128 · FDA decision

    Normal 180 Day Track

  9. P000009/S135 · Related supplement

    Ilivia Neo 7 DRT, Intica Neo 7 DRT, Intica Neo 5 DRT, Acticor Sky DR-T, Rivacor Sky DR-T, Rivacor Rise DR-T, Rivacor Aur

Timeline entries are records held by MedtechLedger for P000009. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P000009

Explore the linked device profile

Other records with product code MRM

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Biotronik, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
6024 Jean Rd., Lake Oswego, OR, 97035

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records